← Back to all trials
Not Yet Recruiting
NCT07494396
An AI-Based Erythema Measurement System for Psoriasis Lesions
Conditions: Psoriasis
Sex: All
Ages: 18 Years – 100 Years
Healthy volunteers: No
Enrollment: 50
Sponsor: Khon Kaen University
Location: Khon Kaen University Khon Kaen Changwat Khon Kaen
Summary
Psoriasis is a common chronic inflammatory skin disease. Disease severity is commonly assessed using the Psoriasis Area and Severity Index (PASI), in which erythema is graded subjectively on a 0-4 scale. This visual assessment is prone to significant inter- and intra-rater variability.
Although objective tools such as colorimeters provide accurate erythema measurement, their high cost limits routine clinical use. Smartphone imaging combined with artificial intelligence (AI) offers a practical alternative for objective assessment. However, variability in lighting conditions can affect image consistency. Incorporating a color calibration card enables accurate color normalization.
This study aims to develop and validate an AI-based system for measuring erythema in psoriatic lesions using smartphone images with a color card, compared against a standard colorimeter to assess validity and reliability.
Eligibility Criteria
Inclusion Criteria:
* Adults aged ≥18 years
* Diagnosed with psoriasis by a dermatologist
* Presence of at least five clearly photographable lesions
* Willing and able to take photographs using a smartphone with both a standard color calibration card and a study-specific color card at home weekly, and submit images via Line or email
* Willing to have clinical photographs taken at baseline and at a follow-up visit
* Provides written informed consent to participate in the study
Exclusion Criteria:
* Presence of skin infection or other lesions that may interfere with color assessment (e.g., tattoos)
* Use of self-tanning products or substances that alter skin color
* Inability to perform photography or comply with study procedures
Source: ClinicalTrials.gov (NCT07494396). StuddyBuddy aggregates publicly available trial information.